<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1402" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1402/" /><meta name="ncbi_pagename" content="X-Linked Hyper IgM Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>X-Linked Hyper IgM Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="X-Linked Hyper IgM Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/01/24" /><meta name="citation_author" content="Judith Johnson" /><meta name="citation_author" content="Alexandra H Filipovich" /><meta name="citation_author" content="Kejian Zhang" /><meta name="citation_pmid" content="20301576" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1402/" /><meta name="citation_keywords" content="HIGM1" /><meta name="citation_keywords" content="Hyper-IgM Syndrome 1" /><meta name="citation_keywords" content="X-Linked Hyper-IgM Immunodeficiency" /><meta name="citation_keywords" content="XHIM" /><meta name="citation_keywords" content="Hyper-IgM Syndrome 1" /><meta name="citation_keywords" content="HIGM1" /><meta name="citation_keywords" content="X-Linked Hyper-IgM Immunodeficiency" /><meta name="citation_keywords" content="XHIM" /><meta name="citation_keywords" content="CD40 ligand" /><meta name="citation_keywords" content="CD40LG" /><meta name="citation_keywords" content="X-Linked Hyper IgM Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="X-Linked Hyper IgM Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Judith Johnson" /><meta name="DC.Contributor" content="Alexandra H Filipovich" /><meta name="DC.Contributor" content="Kejian Zhang" /><meta name="DC.Date" content="2013/01/24" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1402/" /><meta name="description" content="X-linked hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG and IgA and normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal, but NK- and T-cell cytotoxicity are frequently impaired. Antigen-specific responses may be decreased or absent. The range of clinical findings varies, even within the same family. More than 50% of males with HIGM1 develop symptoms by age one year, and more than 90% are symptomatic by age four years. HIGM1 usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections, and recurrent or protracted diarrhea associated with failure to thrive. Neutropenia, thrombocytopenia, and anemia are common. Autoimmune and/or inflammatory disorders, such as sclerosing cholangitis, have been reported. Significant neurologic complications, often the result of a CNS infection, are seen in 10%-15% of affected males. Liver disease, including primary cirrhosis and carcinomas (bile duct carcinomas, hepatocellular carcinomas, adenocarcinomas of the liver and gall bladder), and tumors of the gastrointestinal tract (carcinoid of the pancreas, glucagonoma of the pancreas) are common life-threatening complications in adolescents and young adults with HIGM1. Affected males are also at an increased risk for lymphoma, particularly Hodgkin's disease associated with Epstein-Barr virus infection." /><meta name="og:title" content="X-Linked Hyper IgM Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="X-linked hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG and IgA and normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal, but NK- and T-cell cytotoxicity are frequently impaired. Antigen-specific responses may be decreased or absent. The range of clinical findings varies, even within the same family. More than 50% of males with HIGM1 develop symptoms by age one year, and more than 90% are symptomatic by age four years. HIGM1 usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections, and recurrent or protracted diarrhea associated with failure to thrive. Neutropenia, thrombocytopenia, and anemia are common. Autoimmune and/or inflammatory disorders, such as sclerosing cholangitis, have been reported. Significant neurologic complications, often the result of a CNS infection, are seen in 10%-15% of affected males. Liver disease, including primary cirrhosis and carcinomas (bile duct carcinomas, hepatocellular carcinomas, adenocarcinomas of the liver and gall bladder), and tumors of the gastrointestinal tract (carcinoid of the pancreas, glucagonoma of the pancreas) are common life-threatening complications in adolescents and young adults with HIGM1. Affected males are also at an increased risk for lymphoma, particularly Hodgkin's disease associated with Epstein-Barr virus infection." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1402/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/xlhi/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1402/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8B7279E03FE8910000000006010200.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1402_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1402_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/xdp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rickets-xlh/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1402_"><span class="title" itemprop="name">X-Linked Hyper IgM Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: HIGM1, Hyper-IgM Syndrome 1, X-Linked Hyper-IgM Immunodeficiency, XHIM</div><p class="contrib-group"><span itemprop="author">Judith Johnson</span>, MS, <span itemprop="author">Alexandra H Filipovich</span>, MD, and <span itemprop="author">Kejian Zhang</span>, MD, MBA.</p><a data-jig="ncbitoggler" href="#__NBK1402_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1402_ai__"><div class="contrib half_rhythm"><span itemprop="author">Judith Johnson</span>, MS<div class="affiliation small">Project Manager, Divison of Human Genetics <br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@nosnhoj.ahtiduj" class="oemail">gro.cmhcc@nosnhoj.ahtiduj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Alexandra H Filipovich</span>, MD<div class="affiliation small">Professor, Division of Bone Marrow Transplant and Immune Deficiency<br />Cincinnati Children&#x02019;s Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@hcivopilif.asil" class="oemail">gro.cmhcc@hcivopilif.asil</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kejian Zhang</span>, MD, MBA<div class="affiliation small">Associate Professor of Pediatrics<br />Director, Molecular Genetics Laboratory<br />Division of Human Genetics<br />Cincinnati Children's Hospital Medical Center<br />Cincinnati, Ohio<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.cmhcc@gnahz.naijek" class="oemail">gro.cmhcc@gnahz.naijek</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 31, 2007</span>; Last Revision: <span itemprop="dateModified">January 24, 2013</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="xlhi.Summary" itemprop="description"><h2 id="_xlhi_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG and IgA and normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal, but NK- and T-cell cytotoxicity are frequently impaired. Antigen-specific responses may be decreased or absent. The range of clinical findings varies, even within the same family. More than 50% of males with HIGM1 develop symptoms by age one year, and more than 90% are symptomatic by age four years. HIGM1 usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections, and recurrent or protracted diarrhea associated with failure to thrive. Neutropenia, thrombocytopenia, and anemia are common. Autoimmune and/or inflammatory disorders, such as sclerosing cholangitis, have been reported. Significant neurologic complications, often the result of a CNS infection, are seen in 10%-15% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. Liver disease, including primary cirrhosis and carcinomas (bile duct carcinomas, hepatocellular carcinomas, adenocarcinomas of the liver and gall bladder), and tumors of the gastrointestinal tract (carcinoid of the pancreas, glucagonoma of the pancreas) are common life-threatening complications in adolescents and young adults with HIGM1. Affected males are also at an increased risk for lymphoma, particularly Hodgkin's disease associated with Epstein-Barr virus infection.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of HIGM1 is based on a combination of clinical findings, family history, absent or decreased expression of the CD40 ligand (CD40L) protein on flow cytometry following in vitro stimulation of white cells, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>CD40LG</i> (previously known as <i>TNFSF5</i> or <i>CD154</i>), the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is known to cause HIGM1. Direct sequencing of the entire <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> and <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a>/<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> boundaries detects pathogenic variants in approximately 95% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Allogeneic hematopoietic cell transplantation (HCT) (the only curative treatment currently available), ideally performed prior to onset of life-threatening complications and organ damage; recombinant granulocyte colony-stimulating factor (G-CSF) for chronic neutropenia; appropriate antimicrobial therapy for infections; immunosuppressants for autoimmune disorders.</p><p><i>Prevention of primary manifestations:</i> Prophylaxis for pneumonia secondary to <i>Pneumocystis jiroveci</i>; intravenous immune globulin (IVIG) by age six months to prevent overwhelming infection from encapsulated bacteria.</p><p><i>Prevention of secondary complications:</i> Drink only purified water in areas where cryptosporidium may be in the water supply.</p><p><i>Surveillance:</i> Annual pulmonary function tests after age seven years; annual endoscopic evaluation.</p><p><i>Evaluation of relatives at risk:</i> Evaluate newborn at-risk male relatives with assay of CD40L protein expression by flow cytometry and <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known, so that morbidity and mortality can be reduced by early diagnosis and treatment.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1) is inherited in an X-linked manner. Female carriers are asymptomatic and have no immunologic or biochemical markers of the disorder. Female carriers have a 50% chance of transmitting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy; males who inherit the pathogenic variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the pathogenic variant will be carriers. Affected males pass the pathogenic variant to all their daughters and none of their sons. Carrier testing of at-risk female relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant has been identified in the family.</p></div></div><div id="xlhi.Diagnosis"><h2 id="_xlhi_Diagnosis_">Diagnosis</h2><div id="xlhi.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1) should be considered in males with serum IgG concentration two or more SD below normal for age and any one or more of the following diagnostic criteria from the recommendations of the European Society for Immunodeficiencies [<a class="bk_pop" href="#xlhi.REF10">ESID Working Party 2006</a>]:</p><p><b>Definite diagnosis</b> (decreased serum IgG and one of the following):</p><ul><li class="half_rhythm"><div>Pathogenic variant in <i>CD40LG</i></div></li><li class="half_rhythm"><div>Family history of one or more maternally related males with an HIGM1 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> or diagnosis</div></li></ul><p><b>Probable diagnosis</b> (decreased serum IgG and all of the following):</p><ul><li class="half_rhythm"><div>Normal number of T cells and normal T cell proliferation to mitogens</div></li><li class="half_rhythm"><div>Normal or elevated numbers of B cells but no antigen-specific IgG antibody</div></li><li class="half_rhythm"><div>One or more of the following infections or complications:</div><ul><li class="half_rhythm"><div>Recurrent bacterial infections in the first five years of life</div></li><li class="half_rhythm"><div><i>Pneumocystis carinii</i> infection in the first year of life</div></li><li class="half_rhythm"><div>Neutropenia</div></li><li class="half_rhythm"><div>Cryptosporidium-related diarrhea</div></li><li class="half_rhythm"><div>Sclerosing cholangitis</div></li><li class="half_rhythm"><div>Parvovirus induced aplastic anemia</div></li><li class="half_rhythm"><div>Absent CD40 ligand expression</div></li></ul></li></ul><p><b>Possible diagnosis</b> (decreased serum IgG, normal numbers of T and B cells and one or more of the following):</p><ul><li class="half_rhythm"><div>Serum IgM concentration two or more SD above normal for age</div></li><li class="half_rhythm"><div><i>Pneumocystis carinii</i> infection in the first year of life</div></li><li class="half_rhythm"><div>Parvovirus induced aplastic anemia</div></li><li class="half_rhythm"><div>Cryptosporidium-related diarrhea</div></li><li class="half_rhythm"><div>Severe liver disease (typically sclerosing cholangitis)</div></li></ul></div><div id="xlhi.Testing"><h3>Testing</h3><p>Although no uniform abnormalities are observed on routine immunologic laboratory testing of males with HIGM1, the following test results suggest the diagnosis of HIGM1:</p><ul><li class="half_rhythm"><div>Normal or elevated serum concentrations of IgM&#x000a0;<sup>1</sup> and IgD&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Absent or very low serum concentrations of IgG&#x000a0;<sup>2</sup> and IgA&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Absent IgG specific antibodies</div></li><li class="half_rhythm"><div>Normal or increased number of B cells&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>Normal number and distribution of CD4+ and CD8 + T-cell subsets&#x000a0;<sup>3</sup></div></li><li class="half_rhythm"><div>Normal T-cell proliferation in response to mitogens&#x000a0;<sup>3</sup></div></li></ul><p>Notes:</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">A minority of males with HIGM1 have decreased IgM concentrations.</p></dd><dt>2.</dt><dd><p class="no_top_margin">Serum concentrations of IgM, IgD, IgG, IgA, and B-cell markers are not reliable in a neonate.</p></dd><dt>3.</dt><dd><p class="no_top_margin">Enumeration of lymphocyte subsets, mitogen responses, and other tests of cell-mediated immunity can vary from person to person and over time in a specific person.</p></dd></dl><p><b>Measurement by flow cytometry of CD40 ligand (CD40L) protein expression after in vitro stimulation of T cells.</b> In the resting state, only a low level of CD40L protein expression is seen on normal CD4+ T cells. After in vitro stimulation:</p><ul><li class="half_rhythm"><div class="half_rhythm">Controls show increased expression (up-regulation) of CD40L protein in the majority of CD4+ T cells.</div><div class="half_rhythm">Note: Infants under age six months may not express normal amounts of CD40L protein [<a class="bk_pop" href="#xlhi.REF.gilmour.2003.256">Gilmour et al 2003</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Persons with HIGM1 do not show increased expression of CD40L protein in CD4+ T cells.</div></li></ul><div id="xlhi.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>CD40LG</i> (previously known as <i>TNFSF5</i> or <i>CD154</i>) is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is known to cause <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1).</p><div id="xlhi.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in X-Linked Hyper IgM Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1402/table/xlhi.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlhi.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_2" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_3" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th><th id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th></tr><tr><th headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Affected Males</th><th headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4" id="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Females</th></tr></thead><tbody><tr><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CD40LG</i></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants&#x000a0;<sup>5</sup></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">95%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>7</sup></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(Multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a></td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%</td><td headers="hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_1_4 hd_h_xlhi.T.molecular_genetic_testing_used_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="xlhi.TF.1.1"><p class="no_margin">See <a href="/books/NBK1402/#xlhi.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="xlhi.TF.1.2"><p class="no_margin">See <a href="#xlhi.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="xlhi.TF.1.3"><p class="no_margin">The ability of the test method used to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is present in the indicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a></p></div></dd><dt>4. </dt><dd><div id="xlhi.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/unknown-significance/">unknown significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="xlhi.TF.1.5"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, multiexon, or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>6. </dt><dd><div id="xlhi.TF.1.6"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>7. </dt><dd><div id="xlhi.TF.1.7"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA; included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>8. </dt><dd><div id="xlhi.TF.1.8"><p class="no_margin">Although it is technically feasible for this method to detect a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> female whether or not the deletion has previously been identified in the family, some laboratories may offer deletion testing only to those at-risk women whose family-specific deletion is known.</p></div></dd></dl></div></div></div></div></div><div id="xlhi.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> with the following findings:</p><ul><li class="half_rhythm"><div>Absent or very low serum concentrations of IgG and IgA</div><div>Note: These findings are not universal.</div></li><li class="half_rhythm"><div>Normal or elevated serum concentrations of IgM and IgD</div></li><li class="half_rhythm"><div>Normal:</div><ul><li class="half_rhythm"><div>Number and distribution of CD4+ and CD8+ T-cell subsets</div></li><li class="half_rhythm"><div>T-cell proliferation in response to mitogens</div></li><li class="half_rhythm"><div>Number of B cells</div></li></ul></li></ul><p>Perform the following tests:</p><ul><li class="half_rhythm"><div>Assay for absent or decreased CD40L protein expression</div></li><li class="half_rhythm"><div>Molecular genetic testing of <i>CD40LG</i>, first using <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>. If lack of amplification suggests a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, it must be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</div></li></ul><p><b>Carrier testing for at-risk relatives</b> requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p>Note: (1) Carriers are heterozygotes for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder and typically do not develop clinical findings related to the disorder. (2) Identification of female carriers requires either (a) prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family or, (b) if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is not available for testing, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> first by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, and then, if no pathogenic variant is identified, by methods to detect gross structural abnormalities.</p><p><b>Predictive testing for at-risk asymptomatic males</b> is facilitated by prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p>If a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been previously documented in the family, full <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>CD40LG</i> in the at-risk newborn will detect a pathogenic variant. If lack of amplification suggests a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>, it must be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p><p><b>Prenatal diagnosis and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="xlhi.Clinical_Characteristics"><h2 id="_xlhi_Clinical_Characteristics_">Clinical Characteristics</h2><div id="xlhi.Clinical_Description"><h3>Clinical Description</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1), a disorder of abnormal T- and B-cell function, is characterized by low serum concentrations of IgG and IgA and normal or elevated serum concentrations of IgM. Mitogen proliferation may be normal but NK- and T-cell cytotoxicity is frequently impaired. Antigen-specific responses may be decreased or absent. The range of clinical findings varies, even within the same family. More than 50% of males with HIGM1 develop symptoms by age one year, and more than 90% are symptomatic by age four years [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>].</p><p>HIGM1 usually presents in infancy with recurrent upper- and lower-respiratory tract bacterial infections, opportunistic infections, and recurrent or protracted diarrhea. Hematologic disorders including neutropenia, thrombocytopenia, and anemia are common [<a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>].</p><p>Autoimmune and/or inflammatory disorders (e.g., sclerosing cholangitis) have been reported [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.jesus.2008.s62">Jesus et al 2008</a>, <a class="bk_pop" href="#xlhi.REF.bussone.2009.332">Bussone &#x00026; Mouthon 2009</a>]. Liver disease (including primary cirrhosis and carcinomas) in addition to tumors of the gastrointestinal tract are common life-threatening medical complications in adolescents and young adults with HIGM1.</p><p><b>Infection.</b> Increased susceptibility to recurrent bacterial infections results in pneumonia, frequent sinopulmonary infections, and recurrent otitis media in infancy and childhood. Invasive fungal infections (primarily <i>Candida</i>, <i>Cryptococcus</i>, and <i>Histoplasma</i>) present a significant risk in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#xlhi.REF.antachopoulos.2010.1335">Antachopoulos 2010</a>]. Boys with HIGM1 are also at a significant risk for opportunistic infections from <i>Pneumocystis jeroveci</i> (formerly known as <i>Pneumocystis carinii</i> (PCP) and <i>Cryptosporidium parvum</i>. <i>Pneumocystis jeroveci</i> pneumonia is the first clinical symptom of HIGM1 in more than 40% of infants with the disorder [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>] and accounts for 10%-15% of the mortality associated with HIGM1 [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>].</p><p><b>Chronic diarrhea and malnutrition.</b> Chronic diarrhea is a frequent complication of HIGM1, occurring in approximately one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>]. Recurrent or protracted diarrhea may result from infection with <i>Cryptosporidium parvum</i> or other microorganisms; however, in at least 50% of males with recurrent or protracted diarrhea, no infectious agent can be detected [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>]. Failure to thrive is a serious complication of chronic diarrhea.</p><p><b>Hematologic abnormalities.</b> Neutropenia, and, less frequently, anemia or thrombocytopenia, occurs in a majority of males with HIGM1 [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>].</p><p><b>Neurologic involvement.</b> Significant neurologic complications, often the result of a CNS infection, are seen in 10%-15% of males with HIGM1 [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>]. However, in at least one half of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals a specific infectious agent cannot be <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>].</p><p><b>Liver disease and liver/gastrointestinal carcinoma.</b> Liver disease, a serious complication of HIGM1, historically was observed in more than 80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males by age 20 years [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>]. Hepatitis and sclerosing cholangitis are frequent and may or may not result from an identifiable infectious agent.</p><p>Malignancies of the liver and gastrointestinal tract including bile duct carcinomas [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.filipovich.2004">Filipovich &#x00026; Gross 2004</a>], hepatocellular carcinomas [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>], carcinoid of the pancreas [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>], glucagonoma of the pancreas [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>], and adenocarcinomas of the liver and gall bladder [<a class="bk_pop" href="#xlhi.REF.hayward.1997.977">Hayward et al 1997</a>] are common complications of HIGM1 in adolescents and young adults and account for approximately 25% of the mortality associated with HIGM1 [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>]. Less commonly, neuroendocrine carcinomas are also seen [<a class="bk_pop" href="#xlhi.REF.erdos.2008.455">Erdos et al 2008</a>].</p><p><b>Lymphoma.</b> Males with HIGM1 have an increased risk for lymphoma, particularly Hodgkin's disease associated with Epstein-Barr virus infection [<a class="bk_pop" href="#xlhi.REF.filipovich.2004">Filipovich &#x00026; Gross 2004</a>].</p><p><b>Other</b> reported complications of HIGM1 include, rarely, autoimmune retinopathy [<a class="bk_pop" href="#xlhi.REF.schuster.2005.235">Schuster et al 2005</a>] and cutaneous granulomas [<a class="bk_pop" href="#xlhi.REF.gallerani.2004.39">Gallerani et al 2004</a>].</p><p><b>Life span.</b> The reported median survival of males with HIGM1 who do not undergo successful allogeneic bone marrow transplantation is less than 25 years [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>]. <i>Pneumocystis jeroveci</i> pneumonia in infancy, liver disease, and carcinomas of the liver and gastrointestinal tract in adolescence or young adulthood are the major causes of death [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>, <a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>].</p></div><div id="xlhi.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Males with HIGM1 show remarkable variability in clinical symptoms.</p><p>In general, no good correlation between <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has been observed in HIGM1 [<a class="bk_pop" href="#xlhi.REF.notarangelo.2000.399">Notarangelo &#x00026; Hayward 2000</a>, <a class="bk_pop" href="#xlhi.REF.prasad.2005.90">Prasad et al 2005</a>].</p><p>The <a class="figpopup" href="/books/NBK1402/table/xlhi.T.selected_cd40lg_pathogenic_varian/?report=objectonly" target="object" rid-figpopup="figxlhiTselectedcd40lgpathogenicvarian" rid-ob="figobxlhiTselectedcd40lgpathogenicvarian">p.Thr254Met</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been reported in three unrelated families with mild disease [<a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>]. Whether or not this is a true association needs to be evaluated with study of additional families with the pathogenic variant.</p></div><div id="xlhi.Penetrance"><h3>Penetrance</h3><p>Penetrance is complete in males with a <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="xlhi.Anticipation"><h3>Anticipation</h3><p>Anticipation has not been documented in HIGM1.</p></div><div id="xlhi.Prevalence"><h3>Prevalence</h3><p>The estimated prevalence of HIGM1 is 2:1,000,000 males [<a class="bk_pop" href="#xlhi.REF.winkelstein.2003.373">Winkelstein et al 2003</a>].</p><p>HIGM1 has been reported in families of European, African, and Asian descent; thus, no evidence exists for a racial or ethnic predilection.</p></div></div><div id="xlhi.Genetically_Related_Allelic_Disorde"><h2 id="_xlhi_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>HIGM1 is the only disorder known to be associated with mutation of <i>CD40LG</i>.</p></div><div id="xlhi.Differential_Diagnosis"><h2 id="_xlhi_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="http://www.omim.org/phenotypicSeries/PS308230" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Immunodeficiency with Hyper-IgM: OMIM Phenotypic Series</a>, a table of similar phenotypes that are genetically diverse.</p><p>The differential diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1) includes the following disorders.</p><p><b>Non <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> forms of HIGM</b></p><ul><li class="half_rhythm"><div><b>HIGM2</b></div><ul><li class="half_rhythm"><div>Pathogenic variants in the activation-induced cytidine deaminase <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (<i>AICDA</i>) result in HIGM2, characterized by abnormalities in B-cell differentiation resulting in recurrent bacterial, respiratory, and gastrointestinal infections, but rarely opportunistic infections. Lymphoid hyperplasia is common [<a class="bk_pop" href="#xlhi.REF.minegishi.2000.203">Minegishi et al 2000</a>, <a class="bk_pop" href="#xlhi.REF.revy.2000.565">Revy et al 2000</a>, <a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div>An <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form of hyper IgM syndrome has been reported in four unrelated families with an identical pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variant (p.Arg190Ter) in <i>AICDA</i> (reference sequence <a href="/nuccore/NM_020661.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020661.2</a>) [<a class="bk_pop" href="#xlhi.REF.durandy.2005.67">Durandy et al 2005</a>].</div></li></ul></li><li class="half_rhythm"><div><b>HIGM3.</b> Biallelic pathogenic variants in <i>CD40</i>, the receptor of CD40LG, are causative. HIGM3 is clinically indistinguishable from HIGM1 [<a class="bk_pop" href="#xlhi.REF.ferrari.2001.12614">Ferrari et al 2001</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>.</div></li><li class="half_rhythm"><div><b>HIGM4.</b> Fifteen individuals with an unidentified form of HIGM with decreased production of IgG and a somewhat milder clinical course than HIGM2 have been reported [<a class="bk_pop" href="#xlhi.REF.imai.2003.136">Imai et al 2003</a>]. The genetic defect(s) underlying HIGM4 has not been determined.</div></li><li class="half_rhythm"><div><b>HIGM5.</b> Biallelic pathogenic variants in <i>UNG</i> are causative. HIGM5 resembles HIGM2. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> [<a class="bk_pop" href="#xlhi.REF.imai.2003.136">Imai et al 2003</a>].</div></li></ul><p><b>Common variable immunodeficiency (CVID),</b> particularly hypogammaglobulinemia identified in the first decade of life. As in HIGM1, CD40LG protein may be reduced in individuals with CVID. In contrast to HIGM1, CVID may be associated with a decreased number of total T cells or decreased T-cell function. The genetic etiology of most cases of CVID is currently unknown. See <a class="bk_pop" href="#xlhi.REF.goldacker.2005.504">Goldacker &#x00026; Warnatz [2005]</a>, <a class="bk_pop" href="#xlhi.REF.salzer.2006.377">Salzer &#x00026; Grimbacher [2006]</a>, <a class="bk_pop" href="#xlhi.REF.park.2011.41">Park et al [2011]</a>, and <a class="bk_pop" href="#xlhi.REF.yong.2011.47">Yong et al [2011]</a> for current reviews of CVID.</p><p><b>Severe combined immunodeficiency.</b> Any one of the severe combined immunodeficiencies (SCIDs) must be considered in infants presenting with <i>Pneumocystis jeroveci</i> pneumonia. SCID usually presents with absent T-cell function, quantitative abnormalities of T lymphocyte populations, and markedly decreased mitogen function irrespective of SCID <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>. <a href="/books/n/gene/x-scid/">X-linked SCID</a> is caused by pathogenic variants in <i>IL2RG</i>. Biallelic pathogenic variants in multiple other genes result in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of SCID. See <a class="bk_pop" href="#xlhi.REF.sponzilli.2011.5">Sponzilli &#x00026; Notarangelo [2011]</a> and <a class="bk_pop" href="#xlhi.REF.aloj.2012.43">Aloj et al [2012]</a>.</p><p><b>Agammaglobulinemia.</b> Any one of the disorders associated with agammaglobulinemia should be considered as part of the differential diagnosis of HIGM1. <a href="/books/n/gene/xla/">X-linked agammaglobulinemia</a> (XLA) typically presents in the first year of life with recurrent bacterial infections. Opportunistic viral infections such as <i>Pneumocystis jeroveci</i> pneumonia are rare, as are hematologic disorders such as neutropenia. In contrast to HIGM1, XLA typically presents with absence of CD19+ B cells. XLA is caused by pathogenic variants in <i>BTK</i>. Pathogenic variants in several other genes result in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> forms of agammaglobulinemia. See <a class="bk_pop" href="#xlhi.REF.bonilla.2006.s435">Bonilla &#x00026; Geha [2006]</a> for a current review of these disorders.</p><p><b>HIV infection.</b> Infection with HIV should be considered in any infant presenting with <i>Pneumocystis jeroveci</i> pneumonia.</p><p><b>Transient hypogammaglobulinemia of infancy.</b> Transient hypogammaglobulinemia of infancy is characterized by normal antibody production, normal growth patterns, and lack of opportunistic infections.</p><p><b><i>IKBKG</i>.</b> Pathogenic variants in <i>IKBKG</i> (formerly known as <i>NEMO</i>) may result in a hyper IgM syndrome, generally associated with <a href="/books/n/gene/x-hed/">hypohydrotic ectodermal dysplasia</a> [<a class="bk_pop" href="#xlhi.REF.jain.2001.223">Jain et al 2001</a>]. Serious infections, including opportunistic infections, are a common complication at any age. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a>.</p></div><div id="xlhi.Management"><h2 id="_xlhi_Management_">Management</h2><div id="xlhi.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>Following the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1), the GI and respiratory tracts should be evaluated for overt or occult infections.</p></div><div id="xlhi.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The only curative treatment currently available for HIGM1 is allogeneic hematopoietic cell transplantation (HCT), ideally prior to onset of a life-threatening complication and organ damage [<a class="bk_pop" href="#xlhi.REF.levy.1997.47">Levy et al 1997</a>]. Currently, boys with HIGM1 who receive allogeneic HCT have a 70%-75% long-term survival rate [<a class="bk_pop" href="#xlhi.REF.tomizawa.2004.33">Tomizawa et al 2004</a>, <a class="bk_pop" href="#xlhi.REF.tsuji.2006.469">Tsuji et al 2006</a>]. Modified conditioning regimens prior to HCT may be necessary in individuals with preexisting liver disease [<a class="bk_pop" href="#xlhi.REF.dogu.2011.349">Dogu et al 2011</a>].</p><p>For a concise summary of current clinical management practices in this disorder, see <a class="bk_pop" href="#xlhi.REF.davies.2010.167">Davies &#x00026; Thrasher [2010]</a>.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Total parenteral nutrition may be required.</div></li><li class="half_rhythm"><div>Treat chronic neutropenia with recombinant granulocyte colony-stimulating factor (G-CSF).</div></li><li class="half_rhythm"><div>Institute appropriate antimicrobial therapy for infections.</div></li><li class="half_rhythm"><div>Aggressively evaluate pulmonary infections, including the use of diagnostic bronchoalveolar lavage, to define the specific etiology.</div></li><li class="half_rhythm"><div>Some males with end-stage sclerosing cholangitis have been treated successfully with orthotropic liver transplantation closely associated with allogeneic bone marrow transplantation.</div></li><li class="half_rhythm"><div>Treat lymphomas and GI cancer.</div></li><li class="half_rhythm"><div>Treatment of autoimmune disorders usually involves judicious use of immunosuppressants tailored to the individual's diagnosis.</div></li><li class="half_rhythm"><div>Liver disease, including primary cirrhosis and carcinomas, in addition to tumors of the gastrointestinal tract, complicate the management of older individuals with HIGM1 [<a class="bk_pop" href="#xlhi.REF.lee.2005.1881">Lee et al 2005</a>].</div></li></ul></div><div id="xlhi.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>The following methods are used to prevent infection:</p><ul><li class="half_rhythm"><div><b>Antibiotic prophylaxis.</b> Prophylaxis for pneumonia secondary to <i>Pneumocystis jiroveci</i> (PCP) is indicated because infants with HIGM1 are at high risk of developing PCP during the first two years of life. Typical prophylaxis is Bactrim<sup>&#x000ae;</sup> (trimethoprim-sulfamethoxazole) orally or pentamidine by intravenous or inhalation therapy.</div></li><li class="half_rhythm"><div><b>Intravenous immune globulin (IVIG).</b> IVIG replacement should be considered by the time the child is age six months, as individuals with HIGM1 cannot generate antibodies to encapsulated bacteria naturally and are at risk for overwhelming infection from these organisms. IVIG is a highly purified blood derivative (a combination of many specific antimicrobial antibodies) that is typically given every three to four weeks or can be given subcutaneously, usually on a weekly basis.</div></li><li class="half_rhythm"><div><b>Additional antibiotic prophylaxis</b> should be evaluated on a case-by-case basis.</div></li><li class="half_rhythm"><div><b>Routine childhood immunizations</b> (killed vaccines) may be safely administered but do not preclude the need for IVIG replacement.</div></li></ul></div><div id="xlhi.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>In areas where cryptosporidium may be present in the water supply, only purified water should be ingested.</p></div><div id="xlhi.Surveillance"><h3>Surveillance</h3><p>Monitor and treat pulmonary complications:</p><ul><li class="half_rhythm"><div>Annual pulmonary function tests for those older than age seven years</div></li><li class="half_rhythm"><div>Follow-up of pulmonary infiltrates with a high-resolution chest CT scan, as they may represent lymphoid aggregates</div></li><li class="half_rhythm"><div>Bronchoscopic evaluations as indicated</div></li></ul><p>Perform annual endoscopic evaluation.</p><p>At routine visits, monitor for the following:</p><ul><li class="half_rhythm"><div>Chronic neutropenia</div></li><li class="half_rhythm"><div>Chronic diarrhea and resulting malnutrition. If present, screen for ova and parasites.</div></li><li class="half_rhythm"><div>Liver disease with biochemical liver function tests, especially in individuals with documented history of cryptosporidiosis</div></li><li class="half_rhythm"><div>Lymphomas and GI cancers by history of new symptoms that could be suggestive of malignancy</div></li><li class="half_rhythm"><div>Autoimmune disorders with history, physical examination, and CBC</div></li><li class="half_rhythm"><div>Neurologic complications with neurologic examinations and brain MRI, as indicated</div></li></ul></div><div id="xlhi.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to perform <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>CD40LG</i> if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known so that morbidity and mortality can be reduced by early diagnosis and treatment.</p><p>See <a href="#xlhi.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="xlhi.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="xlhi.Genetic_Counseling"><h2 id="_xlhi_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="xlhi.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyper IgM syndrome (HIGM1) is inherited in an X-linked manner.</p></div><div id="xlhi.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have HIGM1 nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>. Female carriers of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CD40LG</i> are asymptomatic and have no immunologic or biochemical markers of the disorder.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> analysis reveals that the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. <i>De novo</i> pathogenic variants occur in approximately one third of affected individuals with no previous family history of the disorder. Therefore, the mother of an affected male who has no family history of HIGM1 has a 2/3 chance of being a carrier of the <i>CD40LG</i> pathogenic variant.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother.</div></li><li class="half_rhythm"><div>If the mother is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Male sibs who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the variant will be carriers.</div></li><li class="half_rhythm"><div>Female carriers of <i>CD40LG</i> pathogenic variants are asymptomatic and have no immunologic or biochemical markers of the disorder.</div></li><li class="half_rhythm"><div>Germline <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> has been demonstrated in this condition. Thus, even if the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified in DNA extracted from the mother's leukocytes, the sibs remain at increased risk.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Males will pass the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters and none of their sons.</div></li><li class="half_rhythm"><div>Female carriers of a <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are asymptomatic and have no immunologic or biochemical markers of the disorder.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts or other maternal relatives and their offspring may be at risk of being carriers of a <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (if female) or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with a <i>CD40LG</i>-related disorder (if male). The precise risk to the proband's maternal relatives depends on the family relationships.</p></div><div id="xlhi.Carrier_Detection"><h3>Carrier Detection</h3><p>Carrier testing of at-risk female relatives is possible if the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male relative.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> has not been performed on an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male in the family, direct sequencing of the coding regions of <i>CD40LG</i> detects pathogenic variants in approximately 95% of female carriers.</p><p>Note: CD40L expression by flow cytometry is not a reliable <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> test.</p></div><div id="xlhi.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#xlhi.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="xlhi.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CD40LG</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for HIGM1 are possible.</p></div></div><div id="xlhi.Resources"><h2 id="_xlhi_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Canadian Immunodeficiencies Patient Organization (CIPO)</b></div><div>362 Concession Road 12</div><div>RR #2</div><div>Hastings Ontario K0L 1Y0</div><div>Canada</div><div><b>Phone:</b> 877-262-2476 (toll-free)</div><div><b>Fax:</b> 866-942-7651 (toll-free)</div><div><b>Email:</b> info@cipo.ca</div><div><a href="http://cipo.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cipo.ca</a></div></li><li class="half_rhythm"><div><b>Jeffrey Modell Foundation/National Primary Immunodeficiency Resource Center</b></div><div>747 Third Avenue</div><div>New York NY 10017</div><div><b>Phone:</b> 866-463-6474 (toll-free); 212-819-0200</div><div><b>Fax:</b> 212-764-4180</div><div><b>Email:</b> info@jmfworld.org</div><div><a href="http://www.info4pi.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.info4pi.org</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>Primary Immunodeficiency Diseases Registry at USIDNET</b></div><div>40 West Chesapeake Avenue</div><div>Suite 308</div><div>Towson MD 21204-4803</div><div><b>Phone:</b> 866-939-7568</div><div><b>Fax:</b> 410-321-0293</div><div><b>Email:</b> contact@usidnet.org</div><div><a href="http://usidnet.org/usidnet-registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Primary Immunodeficiency Registry at USIDNET</a></div></li></ul></div><div id="xlhi.Molecular_Genetics"><h2 id="_xlhi_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="xlhi.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>X-Linked Hyper IgM Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1402/table/xlhi.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlhi.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_xlhi.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_xlhi.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_xlhi.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_xlhi.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_xlhi.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_xlhi.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_xlhi.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/959" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CD40LG</i></a></td><td headers="hd_b_xlhi.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=959" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_xlhi.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P29965" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CD40 ligand</a></td><td headers="hd_b_xlhi.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/CD40LG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CD40LG @ LOVD</a><br /><a href="https://research.cchmc.org/LOVD2/home.php?select_db=CD40LG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (CD40LG)</a><br /><a href="http://structure.bmc.lu.se/idbase/CD40Lbase/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CD40Lbase: Mutation registry for X-linked Hyper-IgM syndrome (CD40LG)</a></td><td headers="hd_b_xlhi.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CD40LG" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CD40LG</a></td><td headers="hd_b_xlhi.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CD40LG[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CD40LG</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="xlhi.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="xlhi.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for X-Linked Hyper IgM Syndrome (<a href="/omim/300386,308230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1402/table/xlhi.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlhi.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300386" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300386</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CD40 LIGAND; CD40LG</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/308230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">308230</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>CD40LG</i> has five coding exons and four introns that span more than 13 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1402/#xlhi.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> To date, no normal variants of <i>CD40LG</i> are associated with a change in the amino acid sequence of this protein. Population studies of DNA from 50 normal females from southern Ohio identified several variants in the <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> sequence, but these are highly unlikely to have any pathogenic effect on CD40 ligand [Zhang et al, unpublished].</p><p><b>Pathogenic variants.</b> To date, about 170 <i>CD40LG</i> pathogenic variants have been published. A database of published <i>CD40LG</i> pathogenic variants can be found at <a href="http://www.hgmd.cf.ac.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgmd.cf.ac.uk</a> (registration required). Pathogenic variants have been described throughout the five exons of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> but are particularly common in the TNF-homology <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 5):</p><ul><li class="half_rhythm"><div>26% of these are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants which may affect core packaging, prevent binding to CD40L, or affect trimer formation [<a class="bk_pop" href="#xlhi.REF.seyama.1998.2421">Seyama et al 1998</a>].</div></li><li class="half_rhythm"><div>20% are <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants that predict premature protein truncation.</div></li><li class="half_rhythm"><div>The remaining pathogenic variants are small deletions/insertions, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> variants, and partial- or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or large insertions.</div></li></ul><div id="xlhi.T.selected_cd40lg_pathogenic_varian" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>CD40LG</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1402/table/xlhi.T.selected_cd40lg_pathogenic_varian/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__xlhi.T.selected_cd40lg_pathogenic_varian_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.-239A&#x0003e;C</td><td headers="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td><td headers="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/58331233" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_000074<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="/protein/4557433" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_000065<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.761C&#x0003e;T</td><td headers="hd_h_xlhi.T.selected_cd40lg_pathogenic_varian_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr254Met</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> CD40 ligand (CD40L) is a small, 261-amino acid transmembrane protein. The protein has three functional domains: an intracytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, a transmembrane domain, and an extracellular domain that shares considerable sequence homology to tumor necrosis factor alpha. CD40 ligand, expressed primarily on CD4+ T cells, binds with CD40 on the surface of B cells to promote immunoglobulin isotype switching. CD40L also plays an important role in T-cell function, particularly in the interaction with monocyte-derived antigen-presenting cells [<a class="bk_pop" href="#xlhi.REF.jain.1999.1151">Jain et al 1999</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants in <i>CD40LG</i> lead to changes in the amino acid sequence, abnormal <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> of the protein, premature truncation of the protein, or complete absence of CD40 ligand protein. Persons with pathogenic variants in <i>CD40LG</i> are unable to make high-affinity functional antibodies and cytokines, resulting in a high incidence of opportunistic infections.</p><p>Inactivation of <i>CD40LG</i> by an AluYb8 element <a class="def" href="/books/n/gene/glossary/def-item/insertion/">insertion</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 has been reported in a young <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual [<a class="bk_pop" href="#xlhi.REF.apoil.2007.17">Apoil et al 2007</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> at position -123 of the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> has been reported to be responsible for the reduction of CD40L protein [<a class="bk_pop" href="#xlhi.REF.van_hoeyveld.2007.497">Van Hoeyveld et al 2007</a>].</p></div><div id="xlhi.References"><h2 id="_xlhi_References_">References</h2><div id="xlhi.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.aloj.2012.43">Aloj G, Giardino G, Valentino L, Maio F, Gallo V, Espisito T, Naddei R, Cirillo E, Pignata C. Severe combined immunodeficiencies: new and old scenarios. <span><span class="ref-journal">Int Rev Immunol. </span>2012;<span class="ref-vol">31</span>:43–65.</span> [<a href="/pubmed/22251007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22251007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.antachopoulos.2010.1335">Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. <span><span class="ref-journal">Clin Microbiol Infect. </span>2010;<span class="ref-vol">16</span>:1335–42.</span> [<a href="/pubmed/20840542" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20840542</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.apoil.2007.17">Apoil PA, Kuhlein E, Robert A, Rubie H, Blancher A. HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene. <span><span class="ref-journal">Immunogenetics. </span>2007;<span class="ref-vol">59</span>:17–23.</span> [<a href="/pubmed/17146684" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17146684</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.bonilla.2006.s435">Bonilla FA, Geha RS. Update on primary immunodeficiency diseases. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2006;<span class="ref-vol">117</span>:S435–41.</span> [<a href="/pubmed/16455342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16455342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.bussone.2009.332">Bussone G, Mouthon L. Autoimmune manifestations in primary immune deficiencies. <span><span class="ref-journal">Autoimmun Rev. </span>2009;<span class="ref-vol">8</span>:332–6.</span> [<a href="/pubmed/19028607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19028607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.davies.2010.167">Davies EG, Thrasher AJ. Update on the hyper immunoglobulin M syndromes. <span><span class="ref-journal">Br J Haematol. </span>2010;<span class="ref-vol">149</span>:167–80.</span> [<a href="/pmc/articles/PMC2855828/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2855828</span></a>] [<a href="/pubmed/20180797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20180797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.dogu.2011.349">Dogu F, Cipe FE, Reisli I, Erden E, Ikinciogullari A. CD40 ligand deficiency with grade III liver fibrosis, transplanted by a treosulphan-based conditioning regimen. <span><span class="ref-journal">Exp Clin Transplant. </span>2011;<span class="ref-vol">9</span>:349–52.</span> [<a href="/pubmed/21967264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21967264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.durandy.2005.67">Durandy A, Revy P, Imai K, Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. <span><span class="ref-journal">Immunol Rev. </span>2005;<span class="ref-vol">203</span>:67–79.</span> [<a href="/pubmed/15661022" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15661022</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.erdos.2008.455">Erdos M, Garami M, R&#x000e1;k&#x000f3;czi E, Zalatnai A, Steinbach D, Baumann U, Kropshofer G, T&#x000f3;th B, Mar&#x000f3;di L. Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: report of four cases and review of the literature. <span><span class="ref-journal">Clin Immunol. </span>2008;<span class="ref-vol">129</span>:455–61.</span> [<a href="/pubmed/18805740" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18805740</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF10">ESID Working Party. Diagnostic criteria for PID: X-linked hyper IgM. Available <a href="https://esid.org/Working-Parties/Clinical/Resources/Diagnostic-criteria-for-PID2#Q16" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2006. Accessed 4-27-17.</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.ferrari.2001.12614">Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2001;<span class="ref-vol">98</span>:12614–9.</span> [<a href="/pmc/articles/PMC60102/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC60102</span></a>] [<a href="/pubmed/11675497" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11675497</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.filipovich.2004">Filipovich L, Gross T. Immunodeficiency and cancer. In: Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG, eds. <em>Clinical Oncology</em>. 3 ed. London, UK: Elsevier/Churchill Livingstone; 2004:287-98.</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.gallerani.2004.39">Gallerani I, Innocenti DD, Coronella G, Berti S, Amato L, Moretti S, Fabbri P. Cutaneous sarcoid-like granulomas in a patient with X-linked hyper-IgM syndrome. <span><span class="ref-journal">Pediatr Dermatol. </span>2004;<span class="ref-vol">21</span>:39–43.</span> [<a href="/pubmed/14871324" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14871324</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.gilmour.2003.256">Gilmour KC, Walshe D, Heath S, Monaghan G, Loughlin S, Lester T, Norbury G, Cale CM. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. <span><span class="ref-journal">Mol Pathol. </span>2003;<span class="ref-vol">56</span>:256–62.</span> [<a href="/pmc/articles/PMC1187335/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1187335</span></a>] [<a href="/pubmed/14514918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14514918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.goldacker.2005.504">Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. <span><span class="ref-journal">Curr Opin Allergy Clin Immunol. </span>2005;<span class="ref-vol">5</span>:504–9.</span> [<a href="/pubmed/16264329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16264329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.hayward.1997.977">Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency lwith hyper-IgM. <span><span class="ref-journal">J Immunol. </span>1997;<span class="ref-vol">158</span>:977–83.</span> [<a href="/pubmed/8993019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8993019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.imai.2003.136">Imai K, Catalan N, Plebani A, Mar&#x000f3;di L, Sanal O, Kumaki S, Nagendran V, Wood P. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class switch recombination. <span><span class="ref-journal">J Clin Invest. </span>2003;<span class="ref-vol">112</span>:136–42.</span> [<a href="/pmc/articles/PMC162294/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC162294</span></a>] [<a href="/pubmed/12840068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12840068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.jain.1999.1151">Jain A, Atkinson TP, Lipsky PE, Slater JE, Nelson DL, Strober W. Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome. <span><span class="ref-journal">J Clin Invest. </span>1999;<span class="ref-vol">103</span>:1151–8.</span> [<a href="/pmc/articles/PMC408278/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC408278</span></a>] [<a href="/pubmed/10207167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10207167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.jain.2001.223">Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. <span><span class="ref-journal">Nat Immunol. </span>2001;<span class="ref-vol">2</span>:223–8.</span> [<a href="/pubmed/11224521" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11224521</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.jesus.2008.s62">Jesus AA, Duarte AJ, Oliveira JB. Autoimmunity in hyper-IgM syndrome. <span><span class="ref-journal">J Clin Immunol. </span>2008;<span class="ref-vol">28</span> Suppl 1:S62–6.</span> [<a href="/pubmed/18246414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18246414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.lee.2005.1881">Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:1881–90.</span> [<a href="/pubmed/15358621" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15358621</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.levy.1997.47">Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigioni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EAM, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD. Clinical spectrum of X-linked hyper IgM syndrome. <span><span class="ref-journal">J Pediatr. </span>1997;<span class="ref-vol">131</span>:47–54.</span> [<a href="/pubmed/9255191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9255191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.minegishi.2000.203">Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, Dan K, Sedlak D, Buckley RH, Fischer A, Durandy A, Conley ME. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. <span><span class="ref-journal">Clin Immunol. </span>2000;<span class="ref-vol">97</span>:203–10.</span> [<a href="/pubmed/11112359" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11112359</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.notarangelo.2000.399">Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). <span><span class="ref-journal">Clin Exp Immunol. </span>2000;<span class="ref-vol">120</span>:399–405.</span> [<a href="/pmc/articles/PMC1905564/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1905564</span></a>] [<a href="/pubmed/10844515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10844515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.park.2011.41">Park JH, Resnick ES, Cunningham-Rundles C. Perspectives on common variable immune deficiency. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2011;<span class="ref-vol">1246</span>:41–9.</span> [<a href="/pmc/articles/PMC3428018/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3428018</span></a>] [<a href="/pubmed/22236429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22236429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.prasad.2005.90">Prasad ML, Velickovic M, Weston SA, Benson EM. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. <span><span class="ref-journal">J Clin Pathol. </span>2005;<span class="ref-vol">58</span>:90–2.</span> [<a href="/pmc/articles/PMC1770534/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1770534</span></a>] [<a href="/pubmed/15623492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15623492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.revy.2000.565">Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). <span><span class="ref-journal">Cell. </span>2000;<span class="ref-vol">102</span>:565–75.</span> [<a href="/pubmed/11007475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11007475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.salzer.2006.377">Salzer U, Grimbacher B. Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? <span><span class="ref-journal">Curr Opin Rheumatol. </span>2006;<span class="ref-vol">18</span>:377–82.</span> [<a href="/pubmed/16763458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16763458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.schuster.2005.235">Schuster A, Apfelstedt-Sylla E, Pusch CM, Zrenner E, Thirkill CE. Autoimmune retinopathy with RPE hypersensitivity and 'negative ERG' in X-linked hyper-IgM syndrome. <span><span class="ref-journal">Ocul Immunol Inflamm. </span>2005;<span class="ref-vol">13</span>:235–43.</span> [<a href="/pubmed/16019685" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16019685</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.seyama.1998.2421">Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. <span><span class="ref-journal">Blood. </span>1998;<span class="ref-vol">92</span>:2421–34.</span> [<a href="/pubmed/9746782" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9746782</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.sponzilli.2011.5">Sponzilli I, Notarangelo LD. Severe combined immunodeficiency (SCID): from molecular basis to clinical management. <span><span class="ref-journal">Acta Biomed. </span>2011;<span class="ref-vol">82</span>:5–13.</span> [<a href="/pubmed/22069950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22069950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.tomizawa.2004.33">Tomizawa D, Imai K, Ito S, Kajiwara M, Minegishi Y, Nagasawa M, Morio T, Nonoyama S, Mizutani S. Allogeneic hematopoietic stem cell transplantation for seven children with X-linked hyper-IgM syndrome: a single center experience. <span><span class="ref-journal">Am J Hematol. </span>2004;<span class="ref-vol">76</span>:33–9.</span> [<a href="/pubmed/15114594" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15114594</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.tsuji.2006.469">Tsuji Y, Imai K, Kajiwara M, Aoki Y, Isoda T, Tomizawa D, Imai M, Ito S, Maeda H, Minegishi Y, Ohkawa H, Yata J, Sasaki N, Kogawa K, Nagasawa M, Morio T, Nonoyama S, Mizutani S. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years&#x02019; experience of a single team. <span><span class="ref-journal">Bone Marrow Transplant. </span>2006;<span class="ref-vol">37</span>:469–77.</span> [<a href="/pubmed/16435016" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16435016</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.van_hoeyveld.2007.497">Van Hoeyveld E, Zhang PX, De Boeck K, Fuleihan R, Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. <span><span class="ref-journal">Immunology. </span>2007;<span class="ref-vol">120</span>:497–501.</span> [<a href="/pmc/articles/PMC2265910/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2265910</span></a>] [<a href="/pubmed/17244160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17244160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.winkelstein.2003.373">Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. <span><span class="ref-journal">Medicine (Baltimore). </span>2003;<span class="ref-vol">82</span>:373–84.</span> [<a href="/pubmed/14663287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14663287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.yong.2011.47">Yong PF, Thaventhiran JE, Grimbacher B. "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? <span><span class="ref-journal">Adv Immunol. </span>2011;<span class="ref-vol">111</span>:47–107.</span> [<a href="/pubmed/21970952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21970952</span></a>]</div></li></ul></div><div id="xlhi.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.ochs.2008.509">Ochs HD. Patients with abnormal IgM levels:assessment, clinical interpretation and treatment. <span><span class="ref-journal">Ann Allergy Asthma Immunol. </span>2008;<span class="ref-vol">100</span>:509–11.</span> [<a href="/pubmed/18517086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18517086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.shimadzu.1995.67">Shimadzu M, Nunoi H, Terasaki H, Ninomiya R, Iwata M, Kanegasaka S, Matsuda I. Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. <span><span class="ref-journal">Biochim Biophys Acta. </span>1995;<span class="ref-vol">1260</span>:67–72.</span> [<a href="/pubmed/7999797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7999797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="xlhi.REF.thusberg.2007.133">Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency - CD40L mutations. <span><span class="ref-journal">Protein Eng Des Sel. </span>2007;<span class="ref-vol">20</span>:133–41.</span> [<a href="/pubmed/17307885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17307885</span></a>]</div></li></ul></div></div><div id="xlhi.Chapter_Notes"><h2 id="_xlhi_Chapter_Notes_">Chapter Notes</h2><div id="xlhi.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>24 January 2013 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>21 June 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 February 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 May 2007 (me) Review posted to live Web site</div></li><li class="half_rhythm"><div>20 February 2007 (jj) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1402</span><span class="label">PMID: <a href="/pubmed/20301576" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301576</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/xdp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rickets-xlh/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1402&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1402/?report=reader">PubReader</a></li><li><a href="/books/NBK1402/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1402" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1402" style="display:none" title="Cite this Page"><div class="bk_tt">Johnson J, Filipovich AH, Zhang K. X-Linked Hyper IgM Syndrome. 2007 May 31 [Updated 2013 Jan 24]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1402/pdf/Bookshelf_NBK1402.pdf">PDF version of this page</a> (447K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#xlhi.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#xlhi.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#xlhi.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#xlhi.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#xlhi.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#xlhi.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#xlhi.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#xlhi.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#xlhi.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#xlhi.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#xlhi.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=959[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CD40LG</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1460884" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460884" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460884" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1460884" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301357" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chandra S, Bronicki L, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301584" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> X-Linked Severe Combined Immunodeficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Allenspach E, Rawlings DJ, Scharenberg AM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25299040" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Barth Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Barth Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ferreira C, Thompson R, Vernon H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301576" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301576" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040e9e39a66ee2ba72156a">X-Linked Hyper IgM Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">X-Linked Hyper IgM Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:36:30-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8B7279E03FE8910000000006010200&amp;ncbi_session=CE8B7279E040E9E1_1537SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1402%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1402&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1402/&amp;ncbi_pagename=X-Linked Hyper IgM Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8B7279E040E9E1_1537SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>